Respiratory Disease Testing Market, By Test Type (Imaging Test, Spirometry, Peak Flow Test, Blood Gas Test, Lung Volume Test, Others), By End User (Hospitals, Physician Offices, Clinical Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Respiratory diagnostics are the medical products and technologies that are used to diagnose respiratory diseases and disorders in patients. Respiratory diagnostics is effective as it can diagnose diseases at an early stage. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Based on anatomical features, the respiratory system has been segmented into the upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises the pharynx, larynx, and nasal passages, while the lower respiratory tract includes the trachea, lungs, and bronchi. Respiratory disorders, or lung diseases, are disorders such as asthma, cystic fibrosis, emphysema, lung cancer, mesothelioma, pulmonary hypertension, and tuberculosis. If left untreated, lung disease can produce health complications, problematic symptoms, and life-threatening conditions.
Market Dynamics
Development activities such as product launches, approvals, acquisitions, and mergers, among other, are driving the overall market growth. For instance, in November 2021, Cipla Limited, an multinational pharmaceutical company in India, launched Spirofy, India's pneumotach-based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis in India. Such developments are anticipated to contribute to the market growth over the forecast period. For instance, in September 2021, Roche, manufacturing medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche which also specializes in in vitro diagnostics and tissue-based cancer diagnostics, launched three molecular polymerase chain reaction (PCR) diagnostic test panels to simultaneously detect and differentiate common respiratory pathogens. Therefore, such advancements in the segment are expected to fuel segment growth.
Key features of the study:
This report provides an in-depth analysis of the global respiratory disease testing market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global respiratory disease testing market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CareFusion Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation, Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke Philips N.V. ResMed Inc., Medtronic, Abbott Diagnostics, and Quest Diagnostics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global respiratory disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory disease testing
Detailed Segmentation:
Global Respiratory Disease Testing Market, By Test Type:
Imaging Test
Spirometry
Peak Flow Test
Blood Gas Test
Lung Volume Test
Others
Global Respiratory Disease Testing Market, By End User:
Hospitals
Physician Offices
Clinical Laboratories
Global Respiratory Disease Testing Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
CareFusion Corporation
Carestream Health, Inc.
COSMED
Futuremed America, Inc.
GE Healthcare
MGC Diagnostics Corporation
ndd Medical Technologies, Inc.
Nihon Kohden Corporation
Perkin Elmer, Inc.
FUJIFILM Healthcare Corporation
Philips Healthcare
Roche Healthcare
Beckton Dickinson and Company
Koninklijke Philips N.V.
ResMed Inc.
Medtronic
Abbott Diagnostics
Quest Diagnostics.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Test Type
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Respiratory disease testing Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Respiratory disease testing Market, By Test Type, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019–2030
Segment Trends
Imaging Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Spirometry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Peak Flow Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Blood Gas Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Lung Volume Test
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
6. Global Respiratory disease testing Market, By End User, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Physician Offices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Clinical Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
7. Global Respiratory disease testing Market, By Region, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
North America
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, 2018–2030, (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, 2018–2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, 2018–2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, 2018–2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country, 2018–2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Test Type, 2018–2030, (US$ Mn)
Market Size and Forecast, By End User, 2018–2030, (US$ Mn)
Market Size and Forecast, By Country/Region, 2018–2030, (US$ Mn)
North Africa
Central Africa
South Africa
Rest of Africa
8. Company Profiles
CareFusion Corporation *
Products Portfolio
Key Highlights
Financial Performance
Strategies
Carestream Health, Inc.
Products Portfolio
Key Highlights
Financial Performance
Strategies
COSMED
Products Portfolio
Key Highlights
Financial Performance
Strategies
Futuremed America, Inc.
Products Portfolio
Key Highlights
Financial Performance
Strategies
GE Healthcare
Products Portfolio
Key Highlights
Financial Performance
Strategies
MGC Diagnostics Corporation
Products Portfolio
Key Highlights
Financial Performance
Strategies
ndd Medical Technologies, Inc.
Products Portfolio
Key Highlights
Financial Performance
Strategies
Nihon Kohden Corporation
Products Portfolio
Key Highlights
Financial Performance
Strategies
Perkin Elmer, Inc.
Products Portfolio
Key Highlights
Financial Performance
Strategies
FUJIFILM Healthcare Corporation
Products Portfolio
Key Highlights
Financial Performance
Strategies
Philips Healthcare
Products Portfolio
Key Highlights
Financial Performance
Strategies
Roche Healthcare
Products Portfolio
Key Highlights
Financial Performance
Strategies
Beckton Dickinson and Company
Products Portfolio
Key Highlights
Financial Performance
Strategies
Koninklijke Philips N.V.
Products Portfolio
Key Highlights
Financial Performance
Strategies
ResMed Inc.
Products Portfolio
Key Highlights
Financial Performance
Strategies
Medtronic
Products Portfolio
Key Highlights
Financial Performance
Strategies
Abbott Diagnostics
Products Portfolio
Key Highlights
Financial Performance
Strategies
Quest Diagnostics
Products Portfolio
Key Highlights
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 33 market data tables and 30 figures on “Respiratory disease testing Market ”- Global Forecast to 2030